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Ganglioside GM3 Depletion Reverses Impaired
Wound Healing in Diabetic Mice by Activating
IGF-1 and Insulin Receptors
Xiao-Qi Wang1, Sarah Lee1, Heather Wilson1, Mark Seeger1, Hristo Iordanov1, Nandita Gatla1,
Adam Whittington1, Daniel Bach1, Jian-yun Lu1 and Amy S. Paller1
Ganglioside GM3 mediates adipocyte insulin resistance, but the role of GM3 in diabetic wound healing, a
major cause of morbidity, is unclear. The purpose of this study was to determine whether GM3 depletion
promotes diabetic wound healing and directly activates keratinocyte (KC) insulin pathway signaling. GM3
synthase (GM3S) expression is increased in human diabetic foot skin, ob/ob and diet-induced obese diabetic
mouse skin, and in mouse KCs exposed to increased glucose. GM3S knockout in diet-induced obese mice
prevents the diabetic wound-healing defect. KC proliferation, migration, and activation of insulin receptor (IR)
and insulin growth factor-1 receptor (IGF-1R) are suppressed by excess glucose in wild-type cells, but
increased in GM3S  / KCs with supplemental glucose. Co-immunoprecipitation of IR, IR substrate 1 (IRS-1),
and IGF-1R, and increased IRS-1 and Akt phosphorylation accompany receptor activation. GM3 supplementa-
tion or inhibition of IGF-1R or PI3K reverses the increased migration of GM3S / KCs, whereas IR knockdown
only partially suppresses migration.
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INTRODUCTION
Chronic cutaneous ulcerations affect 15% of individuals with
type 2 diabetes (Reiber et al., 1998), often leading to
amputation. The poor wound healing in diabetes has been
linked to impaired insulin receptor (IR)/IGF-1 receptor (IGF-
1R) signaling, accumulation of glycosylated end products,
vasculopathy, neuropathy, and infection (Peppa and Vlassara,
2005; Marston, 2006; Brem and Tomic-Canic, 2007; Acosta
et al., 2008; Markuson et al., 2009; Nouvong et al., 2009; Guo
and Dipietro, 2010; Christman et al., 2011). Although levels of
glycosylated proteins are an accepted measure of glycemic
control and their accumulation has been strongly linked to
impaired acral wound healing in diabetics (Markuson et al.,
2009; Christman et al., 2011), little is known about the role of
increased glycolipids in diabetic wound healing.
Wound healing is a complex process that requires the
activation, migration, and proliferation of keratinocytes (KCs)
to re-epithelialize the wound. Although skin is not a classical
insulin target tissue, both insulin and IGF-1 have been shown
to be potent stimulants of normal KC migration and prolifera-
tion through the activation of IR and IGF-1R (Ando and Jensen,
1993; Li et al., 2006). Indeed, studies in IR-null and IGF-1R-
null mice have shown both IR and IGF-1R to be essential for
normal KC physiology (Sadagurski et al., 2006; Stachelscheid
et al., 2008). Nevertheless, the role of IR/IGF-1R signaling
impairment in the compromised re-epithelialization of
diabetic wounds is not well understood (Usui et al., 2008).
Ganglioside GM3 has been suggested to have an inter-
mediary role in the development of insulin resistance and
diabetes. GM3, a sialylated membrane-based glycosphingoli-
pid, and the enzyme that synthesizes it, GM3 synthase (GM3S;
also called SAT-I/ ST3Gal-V), are increased in the kidneys,
liver, adipose tissues, and muscles of murine models of
diabetes (Zador et al., 1993; Memon et al., 1999; Tagami
et al., 2002). Increased levels of gangliosides have been found
in the serum of diabetic patients with microvascular
complications (Hamed et al., 2011), and GM3S expression
is increased in the kidneys of diabetics with nephropathy (Wei
et al., 2011). Tumor necrosis factor alpha (TNF-a), which
causes insulin resistance, increases GM3S and GM3
expression in canonical insulin target cells (adipocytes,
myocytes, and hepatocytes) (Memon et al., 1999; Tagami
et al., 2002). Glucosylceramide synthase inhibitors deplete
GM3 and reverse TNF-a-induced suppression of IRS-1
tyrosine phosphorylation in adipocytes (Tagami et al., 2002;
Aerts et al., 2007). GM3 directly suppresses IR and IR substrate
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1 (IRS-1) tyrosine phosphorylation in cultured adipocytes,
decreasing glucose uptake (Tagami et al., 2002). Knocking
out GM3S in mice (Yamashita et al., 2003) and treatment of
diabetic mice or rats with glucosylceramide synthase
inhibitors improves insulin sensitivity (Aerts et al., 2007;
Zhao et al., 2007, 2009), ameliorates hepatic steatosis (Zhao
et al., 2009), and suppresses the development of diabetic renal
hypertrophy (Zador et al., 1993). The impact of gangliosides
on IGF-1R activation has never been explored.
We have found increased expression of GM3S in the foot
skin of human diabetics and of GM3S and GM3 in the skin of
diabetic mice. Knocking out GM3S and depleting GM3 fully
prevented the wound-healing impairment of diet-induced obese
(DIO) mice. KCs from GM3S-knockout mice have activated IR
and IGF-1R signaling and, as a result, accelerated migration and
proliferation, particularly in the presence of excess glucose.
We propose that GM3S and GM3 are key molecules in the
development of insulin resistance and are potential targets for
therapies to improve diabetic wound healing.
RESULTS
Increased expression of GM3S in human and mouse diabetic skin
Human diabetic foot skin had a 4.1-fold increase in GM3S
mRNA expression in comparison with age- and site-matched
controls (Figure 1a). In the skin of two diabetic mouse models,
ob/ob (leptin-deficient) and C57BL/6 mice fed a high-fat diet
(HFD) for 10 weeks (DIO), GM3S mRNA expression was
increased by 4.2-fold and by 3.0-fold, respectively
(Figure 1b), and GM3 by 2.8- and 2.6-fold, respectively
(Figure 1c). GM3 and GM3S were virtually undetectable in
GM3S / mouse skin.
GM3S depletion reverses the wound healing defect in DIO mice
To explore the effect of GM3S expression on wound healing
in vivo, we compared the wound healing of GM3S / with
GM3þ /þ littermate (WT) mice. Initially, we confirmed the
partial prevention of insulin resistance in GM3S / mice fed
a HFD for 10 weeks as previously described (Yamashita et al.,
2003) (Supplementary Figure S1 online). GM3S / HFD
mice were as obese as their WT HFD littermates and showed
high mean fasting glucose levels, but had normal-fed insulin
and glucose levels 120 minutes after glucose challenge.
To more closely simulate human wound healing and
reduce mouse skin contraction, we used a silicone-splinted
wound-healing model (Galiano et al., 2004), which allows
healing primarily by re-epithelialization. Wound closure was
visibly delayed in WT HFD mice by 5 days after wound
initiation (Figure 2a and b), but wound closure in GM3S /
HFD and RD mice was similar. By only 3 days after
wounding, the epidermal gap was greater in WT HFD versus
other mice, including GM3S / HFD mice (Figures 2c,
Po0.05) and increased progressively (Po0.001 for 5 and 7
days). Full epidermal closure required 14.1 days in WT HFD
mice, but 7.4 days in GM3S / HFD mice, and the rate was
equal at all time points for GM3S / HFD, GM3S / RD,
and WT RD mice (Figure 2c). Granulation tissue area was
smaller in WT HFD wounds than in wounds from GM3S /
HFD mice (Figures 2d, Po0.05 at 5 days and Po0.001 at 7
days; Supplementary Figure S2 online), but the same in WT
RD and GM3S / HFD mouse wounds. WT HFD epidermis
on day-3 wounds had fewer bromodeoxyuridine-positive
(BrdUþ ) proliferating basal KCs (Po0.05; Figure 2e) and a
smaller migrational distance (Po0.05; Figure 2f) than other
mouse epidermis. These studies suggest that the accelerated
wound healing in vivo, at least in part, is related to the
observed increase in both KC proliferation and migration.
Immunohistochemical analyses show that GM3S knockout
reversed the deficit in p-IGF-1R staining seen in WT HFD
mouse wound skin (Supplementary Figure S3 online).
Increased glucose exposure stimulates GM3S / KC migration
and proliferation
Pre-incubation of WT primary mouse KCs in 20 mM glucose
for 72 hours, traditionally used to simulate the hyperglycemic
diabetic environment in vitro (Ingram et al., 2008; Suzuki
et al., 2011), stopped migration in in vitro wounds (Figure 3a
and b) and reduced cell proliferation (Figure 3c) (Spravchikov
et al., 2001; Terashi et al., 2005; Lan et al., 2008). GM3S /
cells migrated faster than WT cells by 24 hours after wounding
in normoglycemic conditions. In hyperglycemic medium,
GM3S / KCs closed wounds (Figure 3a and b) and prolif-
erated faster (Figure 3c) than GM3S / in normoglycemic
medium or WT cells in normoglycemic or hyperglycemic
medium. Addition of supplemental GM3 eliminated the
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Figure 1. GM3 synthase and GM3 are increased in human and mouse
diabetic skin. (a) Digital droplet PCR to measure GM3S expression in mRNA
extracted from non-wounded human plantar skin (n¼ 6, type 2 diabetics (DM);
n¼ 5, age- and site-matched controls). mRNA is measured as copies per nl of
PCR product. ***Po0.001. (b, c) Back skin was excised from DIO WT (high-fat
diet (HFD) for 10 weeks), ob/ob, GM3S / (HFD; RD), and WT (RD) mice
(n¼ 5 in each group) for mRNA and glycosphingolipid extraction. qRT-PCR
analysis (b) shows three runs in triplicate. Thin-layer chromatography
immunostaining with anti-GM3 antibody (c) is representative of five runs,
shown densitometrically (Std¼GM3 standard). Results are expressed as
mean±SD. ***Po0.001, mouse DIO WT and ob/ob versus WT RD or
GM3S / ; GM3S / mice versus WT RD controls.
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protective effect of GM3S depletion on glucose-induced
suppression of migration and proliferation; no statistically
significant difference was found when GM3S / versus WT
KCs were treated with the combination of GM3 and high
glucose at any time point (Figure 3a–c). In WT KCs, high
glucose increased expression of GM3, as shown by
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Figure 2. Ganglioside depletion accelerates wound healing in DIO mice. GM3S / mice and wild type (WT, GM3Sþ /þ ) on a regular (RD) or high-fat diet
(HFD) for 10 weeks. (a) Representative image ofX20 wounds each group and time point. (b) Computerized measurements of open wound area. Epidermal gap (c)
and granulation tissue area (d) measured by computerized morphometry. (e) In vivo proliferation as number of BrdU-positive basal keratinocytes (KCs). (f) Basal KC
migration as epidermal length from wound edge to first BrdU-positive cell. At least 20 sections were analyzed for BrdU detection (3-day wounds) for each mouse
group. Data shown are means±SE. *Po0.05, ***Po0.001, for comparison of WT HFD with other mice and conditions, including GM3S / HFD.
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immunofluorescence (Figure 3d) and GM3S, as shown by
western blotting (Figure 3e). Addition of the GM3 metabolic
precursor lactosylceramide (LacCer), which is increased in
GM3S knockout cells (Supplementary Figure S4a online), did
not affect WT KC proliferation (Supplementary Figure S4b
online) and decreased cell migration (Supplementary
Figure S4c and d online). These findings suggest that the
increase in KC migration and proliferation, particularly with
high glucose exposure, results directly from the depletion of
GM3 and not from increased LacCer.
GM3S depletion activates IR and IGF-1R signaling
GM3S depletion markedly increased IR and IGF-1R phosphor-
ylation and downstream activation, as shown in Figure 4a–e,
but did not affect receptor expression (Supplementary Figure S5
online). When cells were grown in normoglycemic medium
(all panels on the left of Figure 4), starved overnight, and
stimulated with insulin, p-IR was 1.6-fold greater in GM3S /
KCs than in WT KCs (Figure 4a, top row and graph, lane 5 vs 2;
Supplementary Figure S5a, 2nd row online). Under similar
conditions, IGF-1 induced sevenfold more p-IR in GM3S /
KCs than it did in WT KCs (Figure 4a, top row, lane 6 vs 3;
Supplementary Figure S5a, left, 2nd row online). In hypergly-
cemic medium for 72 hours (all panels on the right of Figure 4),
p-IR responses to insulin and IGF-1 were reduced in WT cells
but were increased in GM3S / KCs (Figure 4a, lanes 7–12;
Supplementary Figure S5a online, right, 2nd rows).
p-IGF-1R was 2.5-fold greater in normoglycemic medium
after insulin stimulation and 1.9-fold greater after IGF-1
stimulation in GM3S-deficient versus WT cells (Figure 4b,
top row, lanes 5 vs 2 and 6 vs 3; Supplementary Figure 5a,
bottom row online). In hyperglycemic medium, p-IGF-1R was
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markedly reduced in WT KCs in the presence of either insulin
(Figure 4b, lane 8 vs 2) or IGF-1 (Figure 4b, lane 9 vs 3).
Despite exposure to high glucose, insulin-stimulated p-IGF-1R
was maintained and IGF-1-stimulated p-IGF-1R was increased
by 82% in GM3S / KCs (Figure 4b, lanes 11 vs 5 and 12 vs
6, respectively). Even without growth factor stimulation, IGF-
1R was activated in GM3S / KCs and was further increased
by 37% in the presence of supplemental glucose (Figure 4b,
top row, lane 10 vs 4). Supplemental glucose did not
affect IR or IGF-1R expression (Supplementary Figure S5b
and c online).
GM3S depletion increases the association of IR, IRS-1, and
IGF-1R
In KCs, the activation of IR or IGF-1R promotes their associa-
tion with insulin receptor substrate 1 (IRS-1) (Sadagurski et al.,
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2007), thereby activating IRS-1, phosphatidylinositol-3 kinase
(PI3K), AKT, and other downstream pathway components. As
expected, stimulation of WT KCs with insulin or IGF-1
led to the association of IRS-1with IR (Figure 4c, 2nd row,
lanes 3 and 4, respectively) and IGF-1R (Figure 4c, 5th row,
lanes 3 and 4, respectively). In GM3S / KCs, the insulin-
and IGF-1-induced association of IRS-1 with IR (Figure 4c, 2nd
row, lanes 6–7 vs 3–4) was greater than that in WT KCs by
fourfold and fivefold, respectively. The association of IRS-1
with IGF-1R was increased in GM3S / versus WT KCs by
eightfold after insulin stimulation (Figure 4c, 5th row, lane 6 vs
3) and by sixfold after IGF-1 stimulation (Figure 4c, 5th
row, lane 7 vs 4). Even without growth factor stimulation,
the associations in GM3S / KCs of IRS-1 with IR (Figure 4c,
row 2, lane 5 vs 3) and of IRS-1 with IGF-1R (lane 5 vs 4) were
greater than those in WT cells stimulated with growth factor.
In WT KCs, IGF-1R co-immunoprecipitated with IR and vice
versa (Figure 4c, rows 3 and 6), but only when stimulated with
insulin (lane 3) or IGF-1 (lane 4). The association of IGF-1R
with IR was increased in GM3S / KCs versus WT KCs after
insulin stimulation by 2.3-fold (Figure 4c, row 3, lane 6 vs 3)
and after IGF-1 stimulation by 5.7-fold (Figure 4c, row 3, lane
7 vs 4). In the complementary experiment, the association of
IR with IGF-1R was also increased in GM3S / KCs versus
WT KCs, particularly with IGF-1 stimulation (Figure 4c, row 6,
lane 6 vs 3, and lane 7 vs 4).
Glucose supplementation to WT cells decreased IRS-1 co-
immunoprecipitation with IR in the presence of ligands by
B60% (Figure 4c, row 2, lanes 10–11 vs 3–4) and with IGF-
1R by 92% (Figure 4c, row 5, lanes 10–11 vs 3–4). In contrast,
glucose supplementation to GM3S / cells increased IRS-1
co-immunoprecipitation with IR or IGF-1R by up to 2.7-fold
(Figure 4c, rows 2 and 5, lanes 12–14 vs 5–7). Co-immuno-
precipitation of IR with IGF-1R in ligand-stimulated WT cells
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was virtually eliminated by glucose supplementation
(Figure 4c, rows 3 and 6, lanes 10–11 vs 3–4), but was
maintained or increased by up to twofold in GM3S / cells
(Figure 4c, rows 3 and 6, lanes 12–14 vs 5–7).
GM3S depletion activates IRS-1 and downstream signaling
Increased glucose inhibited insulin- and IGF-1-induced p-IRS-
1 in WT cells by 100% and 20%, respectively (Figure 4d,
bottom row, lanes 10–11 vs 3–4). GM3S depletion led to a
fourfold increase in p-IRS-1 (Figure 4d, bottom row, lanes 6–7
vs 3–4), which more than doubled under hyperglycemic
conditions (Figure 4d, bottom row, lanes 13–14 vs 6–7).
GM3S depletion increased ligand-induced p-AKT at Ser473
by approximately fourfold in normoglycemic medium
(Figure 4e, middle row, lanes 5–6 vs 2–3). Supplemental
glucose eliminated p-AKT in WT cells (Figure 4e, middle row,
lanes 8–9 vs 2–3), but increased p-AKT in GM3S / cells by
7.3- and 2.5-fold with insulin and IGF-1 stimulation, respec-
tively (Figure 4e, middle row, lanes 11–12 vs 5–6). Even
without growth factor stimulation, p-AKT was detectable in
GM3S / KCs and increased fourfold in hyperglycemic
medium (Figure 4e, middle row, lane 10 vs 4). GM3S
depletion and glucose exposure did not affect expression of
IRS-1 (Figure 4d, top row; Supplementary Figure S5d online)
or of AKT (Figure 4e, top row).
IGF-1R is critical for the accelerated migration of GM3S /
KCs
Finally, we addressed the relative importance of IR versus
IGF-1R activation in stimulating GM3S / KC migration.
Small-molecule inhibitors of IR were nonspecific and inhibited
IGF-1R, whereas the IGF-1R inhibitor AG538 did not inhibit
IR phosphorylation. As a result, we transiently transduced an
IR shRNA lentivirus into WT and GM3S / mouse KCs,
which knocked down IR by 55% and reduced p-IR by 87% in
comparison with untreated and control shRNA-transduced
cells, but did not alter IGF-1R expression (Figure 5a) or
phosphorylation. AG538, in contrast, suppressed IGF-1R
activation by 95% without affecting expression or phosphor-
ylation of IR (Figure 5b). To be able to compare the impact of
inhibitors on WT versus GM3S / cells in normal glucose
with GM3S / cells in high glucose, scratch assays were
performed with all cell types and conditions in parallel.
Treatment of WT cells with IR shRNA, AG538, or LY294002
(which inhibits downstream PI3K) reduced in vitro wound
closure after 60 hours by B50%, whereas treatment with the
combination of IR shRNAþAG538 decreased migration to
the same extent as GM3 (50mM), supplemental glucose, or IR
sh/AG538 with or without GM3 or glucose (all 70%)
(Figure 5c, Supplementary Figure S6 online). In contrast, IR
shRNA reduced migration after 60 hours of the GM3S / KCs
without extra glucose by only 26%, whereas AG538, the
combination of IR shRNAþAG538, GM3, and LY294002,
similarly reduced migration by B56% (Figure 5d;
Supplementary Figure S6 online). In the presence of supple-
mental glucose (G), GM3S / KC migration was accelerated.
As in GM3S / KCs grown without high glucose, IR shRNA
only reduced migration by 27%; however, AG538 alone,
LY294002, AG538þ IR shRNA, GM3, and the combination of
AG538þ IR shRNAþGM3 all reversed the stimulatory effect
on migration of GM3S / KCs in high glucose beginning
24 hours after the scratch (and by 60–65% at 60 hours).
Treatment of GM3S / KCs in high glucose with both
inhibitors or GM3 suppressed migration to the same extent
as WT KCs treatment with GM3 and AG538þ IR shRNA
(Figure 5e; Supplementary Figure S6 online). These data
provide further evidence of a key role for the activation of
IGF-1R signaling in accelerated wound healing in GM3S /
HFD mice.
DISCUSSION
Despite intriguing evidence that GM3 is a key intermediary in
the development of insulin resistance in canonical insulin
target tissues, the effect of GM3 depletion on peripheral
tissues and diabetic wound healing has never been explored.
We now show that GM3S depletion fully reverses the
impairment in wound healing in a DIO diabetic mouse
model, despite mouse obesity and only partial improvement
in systemic glucose homeostasis. In this model, increases in
both migration and proliferation of KCs contribute to the
accelerated healing (Seitz et al., 2010). Furthermore, we have
demonstrated a direct effect of GM3S depletion on KC
motility and proliferation in vitro through activation of
insulin/IGF-1 axis signaling.
This stimulatory effect of GM3S depletion on KC motility
and proliferation is intensified when KCs are made ‘diabetic’
through exposure to increased glucose, as opposed to the
marked inhibition of WT KC migration and proliferation by
supplemental glucose. In other studies, we have found that
accumulation of GM3 through gene suppression of enzymes
regulating GM3 metabolism suppresses KC migration and
proliferation (unpublished data, ASP); coupled with the lack
of stimulation of KC migration and proliferation by LacCer, the
GM3S substrate, these data implicate depletion of GM3 itself
as the cause of the stimulatory effects of GM3S knockdown.
Furthermore, these observations suggest a central role for KC
GM3 in the wound-healing defect of obesity-related diabetes
(see schematic, Supplementary Figure S6 online).
In ganglioside-depleted adipocytes, the resultant increase in
insulin sensitivity has been linked to adipocyte IR activation
(Tagami et al., 2002; Kabayama et al., 2005). We have now
shown that GM3 depletion increases IR sensitivity in KCs not
only to insulin but also to IGF-1. Importantly, we have
demonstrated that GM3 affects IGF-1R signaling, which to
our knowledge is previously unreported. At least in KCs, the
impact on IGF-1R appears to be more significant in controlling
cell migration than the effect on IR. Indeed, IGF-1, which is
produced by dermal fibroblasts, stimulates KC proliferation
(Ando and Jensen, 1993; Haase et al., 2003) and accelerates
in vitro (Haase et al., 2003) and in vivo (Jyung et al., 1994;
Jeschke et al., 2004; Semenova et al., 2008) wound healing.
mIGF-1 transgenic mice have a hyperplastic epidermis and
accelerated wound healing (Semenova et al., 2008), whereas
IGF-1R / mice show skin hypotrophy and delayed wound
healing (Liu et al., 1993). Diabetic wounds are deficient in
IGF-1 (Blakytny et al., 2000) and, as we have now
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demonstrated, decreased in IGF-1R activation. In other
studies, we have also found decreased p-IGF-1R, p-IR, and
pSer473-Akt expression by western blotting in the wounds of
WT HFD mice, but not GM3S / HFD or WT RD mice (data
not shown). The prevention of hyperglycemia-induced
suppression of IR and IGF-1R signaling, migration, and
proliferation by GM3S depletion, and its reversal when
exogenous GM3 is added, further suggests that GM3 is a
key mediator of insulin resistance.
Gangliosides are thought to impact signaling primarily at
the membrane level through regulating interactions of lipid
raft components (Sonnino and Prinetti, 2010). Although IR and
IGF-1R localization in primary KC membranes is not
defined, both receptors signal in caveolar lipid rafts in other
cell types (Kabayama et al., 2007; Romanelli et al., 2009;
Sekimoto et al., 2012), and IGF-1R signaling requires
caveolin-1 in KC-derived HaCaT cells (Salani et al., 2010).
In adipocytes, increases in membrane GM3 content by
chronic exposure to low concentrations of TNF-a prevent
the localization of IR to caveolar domains (Kabayama et al.,
2005, 2007; Sekimoto et al., 2012). When GM3 content is
reduced, IR accumulates in these lipid raft domains, associates
to a greater extent with caveolin-1, and is activated
(Kabayama et al., 2005). Ganglioside depletion may
similarly prevent IR, and possibly IGF-1R, from leaving
caveolar domains in KCs, leading to increased receptor
activation and downstream signaling.
MATERIALS AND METHODS
Mouse models, human diabetic skin, and cultured mouse KCs
Human diabetic and age-matched volunteer control plantar foot skin
was obtained after written Northwestern IRB-approved informed
patient consent according to Declaration of Helsinki guidelines;
adipose tissue was removed before analyses. (see Supplementary
Methods online) Mouse studies were approved by Northwestern’s
Animal Care and Use Committee. Male GM3S / mice (Yamashita
et al., 2003) and wild-type (WT) GM3Sþ /þ littermate mice were fed
a regular (RD) or 42% high-fat diet (HFD) for 10 weeks and throughout
analyses. ob/ob mice were from Jackson Labs (Bar Harbor, ME).
Mouse KCs were isolated from GM3S / or WT skin at day 1 of age
(Hamill et al., 2012) and were used at passages 2–3.
Glucose tolerance tests and insulin measurement
Glucose tolerance testing and fed insulin measurements were
performed after 10 weeks on a RD or HFD and at least 1 week
before wounding studies.
Detection of GM3 and gene expression in skin and KCs
Total ganglioside was extracted (Wang et al., 2001) from mouse skin.
GM3 expression was determined by thin-layer chromatography
immunostaining using anti-GM3 antibody with loading normalized
to cell number and densitometry to quantify (DH2, Glycotech,
Gaithersburg, MD) (Wang et al., 2002); the same antibody was
used with FITC secondary antibody to detect GM3 by
immunofluorescence. Gene expression of mouse GM3S, IR, IGF-1R,
and IRS-1 was assessed on extracted total RNA by qRT-PCR and of
human foot skin GM3S by droplet digital PCR (ddPCR) (see
Supplementary Table S1 and Methods online).
In vivo wound-healing analysis
Wounds (5 mm) were made on each side of the dorsal midline to
below the panniculus carnosus and a donut-shaped silicone splint
with a 6-mm inner circle was adhered to the surrounding skin to
prevent contracture (Galiano et al., 2004). Wound closure was
analyzed on days 3, 5, 7, and then every 3 days until healed by
standardized photography and digital imaging. Wounds were
harvested on days 3, 5, and 7, and processed for histologic,
immunohistochemical, and RNA expression studies. All histological
analyses to determine epidermal gap and granulation tissue area and
immunohistochemical studies were performed at Northwestern’s Skin
Disease Research Center.
In vitro proliferation and migration assays
To simulate hyperglycemia, mouse KC medium (8 mM glucose) was
supplemented with 12 mM glucose (Sigma, St Louis, MO) for 72 hours.
Proliferation (measured by Water Soluble Tetrazolium assay) and cell
migration (by scratch assays in the presence of mitomycin C) (Wang
et al., 2003) were performed in (a) WT KCs pretreated for 72 hours
with LacCer (5mM, Matreya LLC, Pleasant Gap, PA) (Mu et al., 2009),
(b) GM3S / KCs pretreated for 48 hours with GM3 (50mM,
Matreya)(Paller et al., 1993), (c) GM3S / and WT cells pretreated
24 hours with IGF-1R-specific inhibitor AG538 (4mM, CalBiochem,
Billerica, CA) or PI3K inhibitor LY294002 (20mM, CalBioChem,
Billerica, MA) or (d) GM3S / and WT cells transduced with IR
shRNA or its vector control (Santa Cruz, Santa Cruz, CA) for 72 hours.
Immunoblotting and immunoprecipitation
Immunoblotting was performed (Wang et al., 2003) to detect IR,
IGF-1R, IRS-1, Akt, GM3S, p-IR, p-IGF-IR, p-IRS-1, pSer473-Akt, and
PY-20. Primary mouse KCs were treated with or without supplemental
glucose in complete medium for 72 hours. Cells were then starved of
growth supplements and stimulated with or without insulin
(5mg ml 1, Sigma) for 15 minutes or IGF-1 (100 ng ml 1, Prospect,
East Brunswick, NJ) for 30 minutes. Selected times represent maximal
stimulation times for each growth factor based on preliminary studies
with exposure times of 5, 15, 30, and 60 minutes; each was
performed 3–5 times. Immunoprecipitation of IR, IGF-1R, and IRS-1
was performed as previously described (Wang et al., 2007) with IgG
as a negative control.
Statistical analysis
Statistical significance of mouse wound-healing data was determined
by ANOVA followed by Fisher’s least significant difference post hoc
testing for individual comparisons; data at each time point was
expressed as means±SE. Mouse skin qRT-PCR and thin-layer chro-
matography data, as well as BrdU tissue-labeling data, were expressed
as means±SD. In vitro KC results and analyses of mouse skin for GM3
and GM3S expression were analyzed by paired Student’s t-test, and
expressed as mean±SD. Po0.05 was considered significant.
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